Investment Partners Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.62M Sell
1,396
-12
-0.9% -$14.2K 0.87% 31
2026
Q2
$1.69M Buy
1,408
+104
+8% +$106K 0.94% 27
2026
Q1
$1.2M Buy
1,304
+52
+4% +$52.7K 0.74% 36
2025
Q4
$1.35M Buy
1,252
+448
+56% +$428K 0.84% 32
2025
Q3
$613K Buy
804
+420
+109% +$313K 0.4% 71
2025
Q2
$299K Buy
384
+39
+11% +$30.3K 0.21% 123
2025
Q1
$285K Buy
+345
New +$287K 0.22% 117

Other funds holding LLY

Investment Partners Asset Management's LLY Position: Q3 2026 in Review

Investment Partners Asset Management reduced its Eli Lilly (LLY) stake by 0.85% in Q3 2026, selling an estimated $14.2K and leaving 1,396 shares worth $1.62M. The position accounts for 0.87% of the portfolio, ranked #31.

Investment Partners Asset Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.69M in Q2 2026. 707 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Investment Partners Asset Management held 1,396 shares of Eli Lilly worth $1.62M as of Q3 2026.
  • Investment Partners Asset Management sold 12 Eli Lilly shares in Q3 2026, an estimated $14.2K.
  • Eli Lilly made up 0.87% of Investment Partners Asset Management's portfolio in Q3 2026, its #31 holding.
  • Investment Partners Asset Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • Investment Partners Asset Management's Eli Lilly position peaked at $1.69M in Q2 2026.
  • 707 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Investment Partners Asset Management's 13F filing for Q3 2026, filed 9 Oct 2026.